CoChat

Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Skeletal muscle secretes factors, termed myokines. We employed differentiated human skeletal muscle cells (hSMC) cultured from Type 2 diabetic (T2D) and non-diabetic (ND) subjects to investigate the impact of T2D on myokine secretion. Following 24 hours of culture concentrations of selected myokines were determined to range over 4 orders of magnitude. T2D hSMC released increased amounts of IL6, IL8, IL15, TNFa, Growth Related Oncogene (GRO)a, monocyte chemotactic protein (MCP)-1, and follistatin compared to ND myotubes. T2D and ND hSMC secreted similar levels of IL1ß and vascular endothelial growth factor (VEGF). Treatment with the inflammatory agents lipopolysaccharide (LPS) or palmitate augmented the secretion of many myokines including: GROa, IL6, IL8, IL15, and TNFa, but did not consistently alter the protein content and/or phosphorylation of IkBa, p44/42 MAPK, p38 MAPK, c-Jun N-terminal kinase (JNK) and NF-kB, nor lead to consistent changes in basal and insulin-stimulated glucose uptake or free fatty acid oxidation. Conversely, treatment with pioglitazone or oleate resulted in modest reductions in the secretion of several myokines. Our results demonstrate that altered secretion of a number of myokines is an intrinsic property of skeletal muscle in T2D, suggesting a putative role of myokines in the response of skeletal muscle to T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0158209

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Myokine secretion from differentiated hSMC obtained from non-diabetic (ND, open bars) and Type 2 Diabetic (T2D, solid bars) subjects. (A) Media concentrations of selected factors after 24 hr of culture. (B) 24 hr secretion normalized against total cell protein for each individual set of cells. N = 8–23 for ND, 8–18 for T2D. (C) Media concentrations after 48 hr in culture. (D) 48 hr secretion normalized against cell protein. n = 8–18 for ND, 5–14 for T2D. Results are average + SEM. *p<0.05 vs ND
Fig 1 Myokine secretion from differentiated hSMC obtained from non-diabetic (ND, open bars) and Type 2 Diabetic (T2D, solid bars) subjects. (A) Media concentrations of selected factors after 24 hr of culture. (B) 24 hr secretion normalized against total cell protein for each individual set of cells. N = 8–23 for ND, 8–18 for T2D. (C) Media concentrations after 48 hr in culture. (D) 48 hr secretion normalized against cell protein. n = 8–18 for ND, 5–14 for T2D. Results are average + SEM. *p<0.05 vs NDCC0 · PubMed Central
Fig 2 Regulation of myokine secretion. (A) Secretion over 24 hr with treatment by LPS (1 mg/mL, open bars) or Pio (10 mM, solid bars). n = 13–19 for ND, 8–21 for T2D. (B) Secretion over 24 hr with treatment by palmitate (0.3 mM, open bars) or oleate (0.3 mM, solid bars). Results are expressed relative to secretion in untreated (control, indicated by dashed line) cells from each individual set of cells, average + SEM, n = 7–10 for ND, 5–10 for T2D *p<0.05 vs paired control
Fig 2 Regulation of myokine secretion. (A) Secretion over 24 hr with treatment by LPS (1 mg/mL, open bars) or Pio (10 mM, solid bars). n = 13–19 for ND, 8–21 for T2D. (B) Secretion over 24 hr with treatment by palmitate (0.3 mM, open bars) or oleate (0.3 mM, solid bars). Results are expressed relative to secretion in untreated (control, indicated by dashed line) cells from each individual set of cells, average + SEM, n = 7–10 for ND, 5–10 for T2D *p<0.05 vs paired controlCC0 · PubMed Central
Fig 3 Regulation of metabolism by treatments that influence myokine secretion. Cells were treated as described in Fig 2, but for 48 hr before assay. (A) Basal (open bars) and insulin-stimulated (hatched bars, 33 nM, 60 min) 2-deoxyglucose uptake. Results expressed relative to untreated control, either basal or insulin-stimulated, in each individual set of cells, average + SEM, n = 9 for ND, 8–10 for T2D. (B) Palmitate oxidation in ND (open bars, n = 3) and T2D (solid bars, n = 5–6) hSMC. *p<0.05 vs paired control
Fig 3 Regulation of metabolism by treatments that influence myokine secretion. Cells were treated as described in Fig 2, but for 48 hr before assay. (A) Basal (open bars) and insulin-stimulated (hatched bars, 33 nM, 60 min) 2-deoxyglucose uptake. Results expressed relative to untreated control, either basal or insulin-stimulated, in each individual set of cells, average + SEM, n = 9 for ND, 8–10 for T2D. (B) Palmitate oxidation in ND (open bars, n = 3) and T2D (solid bars, n = 5–6) hSMC. *p<0.05 vs paired controlCC0 · PubMed Central
Fig 4 Impact of T2D on inflammatory signaling in hSMC. Proteins extracted from ND (open bars) and T2D (solid bars) hSMC under control conditions. (A) Representative western blots. (B) Quantification of protein expression normalized to loading control (ß-actin). Ave + SEM, n = 13–21 for ND, 10–16 for T2D. (C) Protein phosphorylation, expressed as ratio of phosphorylated to total protein. Ave + SEM, n = 13–17 for ND, 9–15 for T2D. *p<0.05 vs ND
Fig 4 Impact of T2D on inflammatory signaling in hSMC. Proteins extracted from ND (open bars) and T2D (solid bars) hSMC under control conditions. (A) Representative western blots. (B) Quantification of protein expression normalized to loading control (ß-actin). Ave + SEM, n = 13–21 for ND, 10–16 for T2D. (C) Protein phosphorylation, expressed as ratio of phosphorylated to total protein. Ave + SEM, n = 13–17 for ND, 9–15 for T2D. *p<0.05 vs NDCC0 · PubMed Central
Fig 5 Regulation of inflammatory signaling in hSMC. ND (open bars) and T2D (solid bars) cells extracted after 48 hr treatment with LPS, Pioglitazone (Pio), palmitate or oleate. Results expressed relative to untreated control for each individual set of cells, Ave + SEM. (A) IkBa protein, n = 7–12 and 6–15 for ND and T2D, respectively. (B) Total and phospho-p38, n = 6–14 and 5–8. (C) Total and phospho-p44/42, n = 7–13 and 7–11. (D) Total and phospho-JNK, n = 9–12 and 3–8. * p<0.05 T2D vs ND. †p<0.05 T2D response vs ND response
Fig 5 Regulation of inflammatory signaling in hSMC. ND (open bars) and T2D (solid bars) cells extracted after 48 hr treatment with LPS, Pioglitazone (Pio), palmitate or oleate. Results expressed relative to untreated control for each individual set of cells, Ave + SEM. (A) IkBa protein, n = 7–12 and 6–15 for ND and T2D, respectively. (B) Total and phospho-p38, n = 6–14 and 5–8. (C) Total and phospho-p44/42, n = 7–13 and 7–11. (D) Total and phospho-JNK, n = 9–12 and 3–8. * p<0.05 T2D vs ND. †p<0.05 T2D response vs ND responseCC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 61 references

Research works printed but not linked: 2

  1. D Patsouris, 2014, Insuloin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in mice and humans, PLOS One
  2. AE Brown, 2015, p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients, Am J Physiol Endocrinol Metab, 308, E63, 10.1152/ajpendo.00115.2014 · DOI

Cited by

See all 66

Metadata

Authors
Ciaraldi, T. P., Ryan, A. J., Mudaliar, S. R., & Henry, R. R.
Affiliations
University of California San Diego (US)
Corresponding author
Ciaraldi, Theodore P.
Venue
PLOS ONE
Published
2016-07-25
Volume
11
Issue
7
Pages
e0158209
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2492452094
Cited by
66
References
61
Citations by year
2026: 2 · 2025: 8 · 2024: 4 · 2023: 12 · 2022: 8 · 2021: 8 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 3
FWCI
4.16
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion, public-domain)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
U.S. Department of Veterans Affairs (1 I01CX00635-01A1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
Keywords
myokines, type 2 diabetes, skeletal muscle, inflammatory cytokines, interleukin-6, interleukin-8, IL-15, TNF-α, MCP-1, follistatin, lipopolysaccharide, palmitate, pioglitazone, oleate, insulin resistance, NF-κB signaling, MAPK signaling, glucose uptake, free fatty acid oxidation
MeSH terms
Cells, Cultured, Diabetes Mellitus, Type 2, Energy Metabolism, Fatty Acids, Female, Glucose, Humans, Male, Middle Aged, Oxidation-Reduction, Signal Transduction, Biomarkers, Case-Control Studies, Cytokines, Culture Media, Conditioned, Muscle, Skeletal, Muscle Fibers, Skeletal, Inflammation Mediators, Chemokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes. https://app.cochat.ai/papers/10.1371/journal.pone.0158209
The paper
Ciaraldi, T. P., Ryan, A. J., Mudaliar, S. R., & Henry, R. R. (2016). Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes. PLOS ONE. https://doi.org/10.1371/journal.pone.0158209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.